Nicolas Mach

12PUBLICATIONS

66CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 12, 2026

A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.

|Jan 06, 2026

Efficacy of Immune Checkpoint Inhibitors and Oncoviruses in Solid Tumors.

Hiba Mechahougui, Léna Royston, Catia Vieira Gomes

|Sep 30, 2025

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Dominic Schmid, Bettina Sobottka, Massimiliano Manzo

|Jul 23, 2024

A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors.

Rémi Vernet, Eugenio Fernandez, Denis Migliorini

|May 03, 2024

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next.

Brian Schulte, Nicolas Mach, Timothée Olivier

|Aug 26, 2023

SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients.

Natacha Bordry, Anne-Claire Mamez, Chiara Fedeli

Pageof 2

Frequent Collaborators

Stefanie Hayoz

Sacha I Rothschild

Francesco Bertoni

Alfredo Addeo

Timothée Olivier

Ilaria Alborelli

Michel Gonzalez

Richard Cathomas

Solange Peters

Emanuele Zucca

Frequent Collaborators

Stefanie Hayoz

Sacha I Rothschild

Francesco Bertoni

Alfredo Addeo